form8-k.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Earliest Event Reported): December 4, 2008
CYTRX
CORPORATION
(Exact
Name of Registrant as Specified in its Charter)
Delaware
(State
or Other Jurisdiction of Incorporation)
000-15327
(Commission
File Number)
|
58-1642740
(I.R.S.
Employer Identification No.)
|
11726
San Vicente Boulevard, Suite 650
Los
Angeles, California
(Address
of Principal Executive Offices)
|
90049
(Zip
Code)
|
(310)
826-5648
(Registrant’s
Telephone Number, Including Area Code)
______________________________
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the Registrant under any of the following
provisions:
¨ Written communications
pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
¨ Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
ITEM
1.01 Entry into a Material Definitive Agreement
On December
4, 2008, CytRx Oncology Corporation, a wholly owned subsidiary of CytRx
Corporation (“we,” “us,” “CytRx” or the “Company”), entered into a sub-sublease
with Red Pine Advisors LLC, as sub-subtenant, with respect to the 25th Floor
offices at 555 Madison Avenue, New York, New York, formerly occupied by Innovive
Pharmaceuticals, Inc., which we acquired in September 2008.
The
sub-sublease covers approximately 5,800 square feet and is for a term expiring
on August 29, 2012, unless earlier terminated in accordance with the
sub-sublease.
We will be
entitled under the sub-sublease to base annual rent, commencing February 4,
2009, of approximately $350,000, plus an amount equal to certain taxes and
operating expenses payable by us to the sub-landlord under our sublease of the
space. At present under our sublease, we pay base annual rent of
approximately $210,000, plus certain taxes and operating expenses.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this Report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
CYTRX
CORPORATION
By: /s/
Mitchell K.
Fogelman
Mitchell K.
Fogelman
Chief Financial
Officer
|
|
|
|
Dated: December
9, 2008 |